Search

Author/Creator Guzman, M

5. Q23 A double blind, cross over, placebo-controlled, phase II trial of Sativex in Huntington's Disease. (29th August 2012)

Authors:
Caldentey, JG; Lopéz-Sendón, JL; Trigo, P; Ruiz, C; Ribas, GG; Aguilar, M; Galvez, MA; Pablo, I; Galve-Roth, I; Sagredo, O; Fernandez-Ruiz, JJ; Guzman, M; García, J
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 83(2012)Supplement 1
Page Start:
A62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer. (4th April 2018)

Authors:
Cruz, C; Castroviejo-Bermejo, M; Gutiérrez-Enríquez, S; Llop-Guevara, A; Ibrahim, Y H; Gris-Oliver, A; Bonache, S; Morancho, B; Bruna, A; Rueda, O M; Lai, Z; Polanska, U M; Jones, G N; Kristel, P; de Bustos, L; Guzman, M; Rodríguez, O; Grueso, J; Montalban, G; Caratú, G
Journal:
Annals of oncology
Issue:
Volume 29:Number 5(2018)
Page Start:
1203
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗